Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: NKGen Biotech (NASDAQ:NKGN), Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Addex Therapeutics (NASDAQ:ADXN).
Moleculin Biotech has a consensus price target of $14.00.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $2.5 last updated November 13, 2024 at 4:55 PM EST.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech’s Q3 earnings are confirmed for Friday, November 8, 2024.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.